Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. - Wikidata - wikimedia - TriplyDB

Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.

Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.

http://www.wikidata.org/entity/Q37175244

about

Portopulmonary hypertension: an update Pulmonary vascular complications of liver disease The genetics of pulmonary arterial hypertension Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series)Pulmonary Arterial Hypertension and the Sex Hormone Paradox.Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function Gender, Estrogen, and Obliterative Lesions in the Lung.Sex differences in the pulmonary circulation: implications for pulmonary hypertension Plasma levels of S100A4 in portopulmonary hypertension Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.Intronic SNP in ESR1 encoding human estrogen receptor alpha is associated with brain ESR1 mRNA isoform expression and behavioral traits Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Portopulmonary hypertension Genetic polymorphism in a VEGF-independent angiogenesis gene ANGPT1 and overall survival of colorectal cancer patients after surgical resection Metabolic and hormonal derangements in pulmonary hypertension: from mouse to man.Sex-dependent influence of endogenous estrogen in pulmonary hypertension.Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.Pulmonary hypertension in women.Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension.Sex and haemodynamics in pulmonary arterial hypertension.Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells.Rescuing the BMPR2 signaling axis in pulmonary arterial hypertension The genetics of pulmonary arterial hypertension in the post-BMPR2 era.Update on pulmonary hypertension 2009.Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.Estrogen paradox in pulmonary hypertension: current controversies and future perspectives.Oestrogen receptor alpha in pulmonary hypertension.SRC-1 Regulates Blood Pressure and Aortic Stiffness in Female Mice.Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with Schistosomiasis.Toward Precision Medicine in Pulmonary Arterial Hypertension Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men.Estrogens in Men: Another Layer of Complexity of Estradiol Metabolism in Pulmonary Hypertension Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females.Gender, sex hormones and pulmonary hypertension.Genetic variation in phosphodiesterase (PDE) 7B in chronic lymphocytic leukemia: overview of genetic variants of cyclic nucleotide PDEs in human disease.Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension.Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response.Pulmonary vascular complications of chronic liver disease: Pathophysiology, imaging, and treatment.Review article: liver transplantation for the pulmonary disorders of portal hypertension.

P2860

Q27000393-86FEC598-573C-4F8E-8E29-0B928A82278D Q27021918-115A2E64-67A6-4EA4-95F2-7F436AE3E3F8 Q27027507-82277368-2437-4B44-A09A-568955BF17CF Q28078976-7EA1AC14-21C8-4D08-8A2A-7A8ED1743726 Q30241478-F21FCBFC-6280-4A62-9B7A-F9C259C5AE7D Q30277940-FAD69D1D-45BD-4A54-A5E2-FB5D024C1CDE Q33567156-9C382797-EE23-4951-9A87-B31C7CDC1159 Q33568826-6A23B715-D59D-417F-A763-7F7F4282450B Q33642831-30A06EFB-2A08-4BFA-8384-8853ED3703DB Q33786374-63B1C8B1-5712-418E-8063-30DF5AA4E7BB Q33803212-3DEB8FED-2F60-40DD-9EB5-9FA6F3A9AA62 Q33965877-CE3B7EDD-8687-46B2-AF86-85CCA63DA379 Q34230336-CE144D1A-A37A-4B8F-BAAF-ED055540F693 Q34245617-D839BFD9-9E5F-47A2-9EB3-AA05123D0DF4 Q34425976-5C19D232-6509-4281-891E-A8E26BDB5DBA Q34524900-A8BEC9E9-4378-4528-A6EA-EE64654C6F5D Q34795939-C0960600-F193-43E2-80AA-11E7FB329385 Q35073135-099A9BA6-56BC-4003-B8DA-ADBD1B2080F4 Q35116055-7A02F2DD-11AD-43A7-9E31-5ABEDD56EEEB Q35262038-022F3550-B693-407C-846E-73C936808C2B Q35410950-443ECE97-4BE8-40A0-A35C-8E6EAEC753CF Q35573919-CDC0F5BA-DF70-4B7C-99AF-BD6503F59711 Q35716098-87854422-7279-423C-ABA1-5B2C77792629 Q36016478-5053DE33-F527-4173-B5C0-B11EA5352B43 Q36120117-B8018ADD-BC6F-48F6-9EFE-A4E52078757C Q36191733-E9DF9426-D167-4093-B909-48743339F141 Q36231819-76E5EE00-04A2-44E0-9CFA-602D085BBA75 Q36421287-99A7782E-AB7C-4F4C-913E-5EE91C45C953 Q36516808-98070E02-28FA-49BA-9778-8172959E0CA0 Q36516839-C5176397-EC6B-4200-851E-CF3C0749604F Q36916062-3D84BF0A-A279-4EAD-A1BC-950C175F4925 Q36916102-59BC1D7E-FDA7-45EC-A226-42E5FB380380 Q37091591-FC20AB3E-D730-4019-9F0D-2829498569E1 Q37133789-547EAEE8-808A-4FA6-B778-6822748F0E58 Q37323162-06A8ADAB-2742-456B-B12D-E17AF7A928CF Q37555387-F177C8E7-8BFC-4C58-8A43-AC37A05249C7 Q37670612-3A064935-EB30-4CB5-9A48-C7245E790BA8 Q37671277-60769FE1-F711-4253-8158-5D4A15BD3B68 Q37875682-B0DDE0E9-06D0-4DD3-85A8-2EE5957E0DFC Q38059261-5C7660FA-F20A-4DD9-9177-281E6F2779F8

P2860

Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.

http://www.wikidata.org/entity/Q37175244

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetic risk factors for porto ...... s with advanced liver disease.

@en

Genetic risk factors for porto ...... s with advanced liver disease.

@nl

type

label

Genetic risk factors for porto ...... s with advanced liver disease.

@en

Genetic risk factors for porto ...... s with advanced liver disease.

@nl

prefLabel

Genetic risk factors for porto ...... s with advanced liver disease.

@en

Genetic risk factors for porto ...... s with advanced liver disease.

@nl

P1433

Q37175244-F843E106-AEA8-48B9-A624-B7FEA3BB9A6D

P1476

Q37175244-A43C8A27-5FDA-439A-8BCE-12B8D8B0105C

P2093

Q37175244-0EC51907-63E5-4382-9972-BC10B7D79C3D

Q37175244-15B0D736-378B-4BBA-8466-8785089C9600

Q37175244-26C3B115-9E6C-494B-9104-72CB0983E667

Q37175244-284B1E23-D1AF-459C-B080-BD8A685645C1

Q37175244-334BD56D-A961-440B-93DF-146001FC2B7C

Q37175244-50A86CC5-009C-42EE-99CF-395636CC63D0

Q37175244-5574AF20-C60D-4BC8-9974-3D595B761E26

Q37175244-7EFAE729-FA95-4CF1-90D5-D8DAFB26A4B2

Q37175244-A3E30F11-D698-42FE-97A3-6C71E598BD42

Q37175244-AA85748B-9604-42A0-A620-6332C4440959

P2860

Q37175244-02BE2710-5823-46AA-A1D7-CD83E0CAF040

Q37175244-085D5259-98CE-4A8F-AE18-C4AFED09AE8C

Q37175244-0EE21F69-45E1-4BF0-9E9C-8A0AE22738E4

Q37175244-167F9BAB-EBCA-4EED-A223-6F08429CC9F7

Q37175244-1B5EE7EE-28DA-4F75-AA13-7426AE670FA8

Q37175244-20659751-26B2-4BA0-91FF-D6F43134E4FF

Q37175244-218524C2-6444-4FE5-9D6B-C792D825A58E

Q37175244-2B19312F-BA60-4982-A49A-DC23A6A7ADD4

Q37175244-2CB38C10-A89A-4021-9DB2-695D83449D6B

Q37175244-33D76B12-ED6C-4DA9-A4C3-5008B2D9A407

P304

Q37175244-FFF937CA-B7FB-421C-AB71-ECFA96A1D336

P31

Q37175244-6ED0C8F1-AB8F-4C98-8084-0965F636C19A

P356

Q37175244-DDEA26AE-4698-4D78-92B6-EAAD6B9C8E04

P407

Q37175244-82175451-6387-47BB-B689-8C90AA6D6B95

P433

Q37175244-217A65B6-C649-4546-9E5B-1B6E0BF11209

P478

Q37175244-AE35C5B3-A804-45CD-8AA1-6BF5BCF5B541

P50

Q37175244-32FEC299-7601-425B-B750-FD0A3138BA6E

P577

Q37175244-A0D4C936-C60E-411F-8829-F81077605071

P698

Q37175244-6E130523-886F-4D70-BDF2-54BCF037DC9A

P921

Q37175244-209A6EFD-65D2-40FB-84FF-9890EBAC9512

Q37175244-E9D78E7D-AE7D-46EC-9D5A-B72F072DB24E

P932

Q37175244-6D7716C3-4866-4E4A-9B87-4D1CE28460C5

P356

RCCM.200809-1472OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Genetic risk factors for porto ...... s with advanced liver disease.

@en

P2093

Daniel Rabinowitz

http://www.w3.org/2001/XMLSchema#string

David B Badesch

http://www.w3.org/2001/XMLSchema#string

Evelyn M Horn

http://www.w3.org/2001/XMLSchema#string

Hocine Tighiouart

http://www.w3.org/2001/XMLSchema#string

Inga Peter

http://www.w3.org/2001/XMLSchema#string

James A Knowles

http://www.w3.org/2001/XMLSchema#string

James F Trotter

http://www.w3.org/2001/XMLSchema#string

Kari E Roberts

http://www.w3.org/2001/XMLSchema#string

Michael B Fallon

http://www.w3.org/2001/XMLSchema#string

Michael J Krowka

http://www.w3.org/2001/XMLSchema#string

P2860

European population substructure: clustering of northern and southern populations

Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia

Haploview: analysis and visualization of LD and haplotype maps

A model to predict survival in patients with end-stage liver disease

Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension

Estradiol attenuates hypoxia-induced pulmonary endothelin-1 gene expression

Replicating genotype-phenotype associations

Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta.

Clinical risk factors for portopulmonary hypertension.

Pulmonary arterial hypertension in France: results from a national registry.

P304

835-842

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200809-1472OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P50

Darren B Taichman

P577

2009-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19218192

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

2675568

http://www.w3.org/2001/XMLSchema#string